Valneva shares tumble after suspension of US chikungunya vaccine licence
(Reuters) -Shares in Valneva slumped around 25% on Monday after the French drugmaker said the United...
25th August, 2025
(Reuters) -Shares in Valneva slumped around 25% on Monday after the French drugmaker said the United...
25th August, 2025
By Olivia Le Poidevin and Nidal al-Mughrabi GAZA CITY/GENEVA/CAIRO (Reuters) -The hunger crisis in G...
22nd August, 2025
HONG KONG (Reuters) -China's Bio-Thera Solutions on Thursday said it has signed an agreement grantin...
21st August, 2025
(Reuters) -Medical-device maker Medtronic raised its fiscal 2026 profit forecast on Tuesday and said...
19th August, 2025
(Reuters) -Novo Nordisk said on Monday that it was launching a new offer for self-paying type 2 diab...
18th August, 2025
(Reuters) -Britain's main stock indexes edged lower on Monday, dragged by losses in financial and en...
18th August, 2025
By Jacob Gronholt-Pedersen COPENHAGEN, DENMARK (Reuters) -Shares in Novo Nordisk rose on Monday, aft...
18th August, 2025
LONDON (Reuters) -Eli Lilly will raise the list price in the UK of its weight-loss and type 2 diabet...
14th August, 2025

(Reuters) -Primary Health Properties said on Tuesday it had secured acceptances for 62.9% of Assura...
12th August, 2025
SHANGHAI (Reuters) -Sanofi said on Tuesday it had stopped supplying Praluent, a popular cholesterol...
12th August, 2025
BERLIN (Reuters) -German pharmaceutical group Bayer announced on Tuesday a deal worth up to $1.3 bil...
12th August, 2025
(Reuters) -Britain's blue-chip index climbed on Monday, led by healthcare and consumer shares, but l...
11th August, 2025